Selected research
Industry Research
Lithium Salts Industry Research Report 2026
Market perspective
The global Lithium Salts market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Lithium Salts is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Lithium Salts is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Lithium Salts is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Lithium Salts include Takeda, Eli Lilly, Pfizer, GlaxoSmithKline, Astrazeneca, Shionogi, Otsuka Pharmaceutical, NHU Group and Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Lithium Salts market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Lithium Salts Market by Company
Takeda
Eli Lilly
Pfizer
GlaxoSmithKline
Astrazeneca
Shionogi
Otsuka Pharmaceutical
NHU Group
Lundbeck
Kanghong Pharma
Intellipharmaceutics
HUAHAI
Bristol-Myers Squibb
APOTEX
Allergan
Lithium Salts Segment by Type
Tablets
Oral Solution
Capsules
Lithium Salts Segment by Application
Hospital
Clinic
Others
Lithium Salts Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lithium Salts market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lithium Salts and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lithium Salts.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lithium Salts manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lithium Salts by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lithium Salts in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablets
- Oral Solution
- Capsules
Applications
- Hospital
- Clinic
- Others
Companies covered
- Takeda
- Eli Lilly
- Pfizer
- GlaxoSmithKline
- Astrazeneca
- Shionogi
- Otsuka Pharmaceutical
- NHU Group
- Lundbeck
- Kanghong Pharma
- Intellipharmaceutics
- HUAHAI
- Bristol-Myers Squibb
- APOTEX
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lithium Salts Market Size (2021-2032)
- 2.2.2 Global Lithium Salts Sales (2021-2032)
- 2.2.3 Global Lithium Salts Market Average Price (2021-2032)
- 2.3 Lithium Salts by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Oral Solution
- 2.3.4 Capsules
- 2.4 Lithium Salts by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lithium Salts Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Lithium Salts Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Lithium Salts Revenue of Manufacturers (2021-2026)
- 3.4 Global Lithium Salts Average Price by Manufacturers (2021-2026)
- 3.5 Global Lithium Salts Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Lithium Salts, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lithium Salts, Product Type & Application
- 3.8 Global Manufacturers of Lithium Salts, Established Date
- 3.9 Global Lithium Salts Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Takeda
- 4.1.1 Takeda Company Information
- 4.1.2 Takeda Business Overview
- 4.1.3 Takeda Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Takeda Lithium Salts Product Portfolio
- 4.1.5 Takeda Recent Developments
- 4.2 Eli Lilly
- 4.2.1 Eli Lilly Company Information
- 4.2.2 Eli Lilly Business Overview
- 4.2.3 Eli Lilly Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Eli Lilly Lithium Salts Product Portfolio
- 4.2.5 Eli Lilly Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer Lithium Salts Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 GlaxoSmithKline
- 4.4.1 GlaxoSmithKline Company Information
- 4.4.2 GlaxoSmithKline Business Overview
- 4.4.3 GlaxoSmithKline Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 GlaxoSmithKline Lithium Salts Product Portfolio
- 4.4.5 GlaxoSmithKline Recent Developments
- 4.5 Astrazeneca
- 4.5.1 Astrazeneca Company Information
- 4.5.2 Astrazeneca Business Overview
- 4.5.3 Astrazeneca Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Astrazeneca Lithium Salts Product Portfolio
- 4.5.5 Astrazeneca Recent Developments
- 4.6 Shionogi
- 4.6.1 Shionogi Company Information
- 4.6.2 Shionogi Business Overview
- 4.6.3 Shionogi Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shionogi Lithium Salts Product Portfolio
- 4.6.5 Shionogi Recent Developments
- 4.7 Otsuka Pharmaceutical
- 4.7.1 Otsuka Pharmaceutical Company Information
- 4.7.2 Otsuka Pharmaceutical Business Overview
- 4.7.3 Otsuka Pharmaceutical Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Otsuka Pharmaceutical Lithium Salts Product Portfolio
- 4.7.5 Otsuka Pharmaceutical Recent Developments
- 4.8 NHU Group
- 4.8.1 NHU Group Company Information
- 4.8.2 NHU Group Business Overview
- 4.8.3 NHU Group Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 NHU Group Lithium Salts Product Portfolio
- 4.8.5 NHU Group Recent Developments
- 4.9 Lundbeck
- 4.9.1 Lundbeck Company Information
- 4.9.2 Lundbeck Business Overview
- 4.9.3 Lundbeck Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Lundbeck Lithium Salts Product Portfolio
- 4.9.5 Lundbeck Recent Developments
- 4.10 Kanghong Pharma
- 4.10.1 Kanghong Pharma Company Information
- 4.10.2 Kanghong Pharma Business Overview
- 4.10.3 Kanghong Pharma Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kanghong Pharma Lithium Salts Product Portfolio
- 4.10.5 Kanghong Pharma Recent Developments
- 4.11 Intellipharmaceutics
- 4.11.1 Intellipharmaceutics Company Information
- 4.11.2 Intellipharmaceutics Business Overview
- 4.11.3 Intellipharmaceutics Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Intellipharmaceutics Lithium Salts Product Portfolio
- 4.11.5 Intellipharmaceutics Recent Developments
- 4.12 HUAHAI
- 4.12.1 HUAHAI Company Information
- 4.12.2 HUAHAI Business Overview
- 4.12.3 HUAHAI Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 HUAHAI Lithium Salts Product Portfolio
- 4.12.5 HUAHAI Recent Developments
- 4.13 Bristol-Myers Squibb
- 4.13.1 Bristol-Myers Squibb Company Information
- 4.13.2 Bristol-Myers Squibb Business Overview
- 4.13.3 Bristol-Myers Squibb Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Bristol-Myers Squibb Lithium Salts Product Portfolio
- 4.13.5 Bristol-Myers Squibb Recent Developments
- 4.14 APOTEX
- 4.14.1 APOTEX Company Information
- 4.14.2 APOTEX Business Overview
- 4.14.3 APOTEX Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 APOTEX Lithium Salts Product Portfolio
- 4.14.5 APOTEX Recent Developments
- 4.15 Allergan
- 4.15.1 Allergan Company Information
- 4.15.2 Allergan Business Overview
- 4.15.3 Allergan Lithium Salts Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Allergan Lithium Salts Product Portfolio
- 4.15.5 Allergan Recent Developments
5 Global Lithium Salts Market Scenario by Region
- 5.1 Global Lithium Salts Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Lithium Salts Sales by Region: 2021-2032
- 5.2.1 Global Lithium Salts Sales by Region: 2021-2026
- 5.2.2 Global Lithium Salts Sales by Region: 2027-2032
- 5.3 Global Lithium Salts Revenue by Region: 2021-2032
- 5.3.1 Global Lithium Salts Revenue by Region: 2021-2026
- 5.3.2 Global Lithium Salts Revenue by Region: 2027-2032
- 5.4 North America Lithium Salts Market Facts & Figures by Country
- 5.4.1 North America Lithium Salts Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Lithium Salts Sales by Country (2021-2032)
- 5.4.3 North America Lithium Salts Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Lithium Salts Market Facts & Figures by Country
- 5.5.1 Europe Lithium Salts Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Lithium Salts Sales by Country (2021-2032)
- 5.5.3 Europe Lithium Salts Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Lithium Salts Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lithium Salts Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Lithium Salts Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Lithium Salts Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lithium Salts Market Facts & Figures by Country
- 5.7.1 South America Lithium Salts Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Lithium Salts Sales by Country (2021-2032)
- 5.7.3 South America Lithium Salts Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Lithium Salts Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lithium Salts Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Lithium Salts Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Lithium Salts Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Lithium Salts Sales by Type (2021-2032)
- 6.1.1 Global Lithium Salts Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Lithium Salts Sales Market Share by Type (2021-2032)
- 6.2 Global Lithium Salts Revenue by Type (2021-2032)
- 6.2.1 Global Lithium Salts Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Lithium Salts Revenue Market Share by Type (2021-2032)
- 6.3 Global Lithium Salts Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Lithium Salts Sales by Application (2021-2032)
- 7.1.1 Global Lithium Salts Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Lithium Salts Sales Market Share by Application (2021-2032)
- 7.2 Global Lithium Salts Revenue by Application (2021-2032)
- 7.2.1 Global Lithium Salts Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Lithium Salts Revenue Market Share by Application (2021-2032)
- 7.3 Global Lithium Salts Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lithium Salts Value Chain Analysis
- 8.1.1 Lithium Salts Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lithium Salts Production Mode & Process
- 8.2 Lithium Salts Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lithium Salts Distributors
- 8.2.3 Lithium Salts Customers
9 Global Lithium Salts Analyzing Market Dynamics
- 9.1 Lithium Salts Industry Trends
- 9.2 Lithium Salts Industry Drivers
- 9.3 Lithium Salts Industry Opportunities and Challenges
- 9.4 Lithium Salts Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst